Mechanism
Disrupt microbial membranes — investigated as targeted anti-infectives amid AMR.
TechnicalAmphipathic cationic peptides bind anionic microbial membranes, forming pores; some modulate host immunity.
Reported uses by species
| Species | Indication | Tier | Honest evidence note |
|---|---|---|---|
| Companion & livestock | Resistant infections — adjunct to/alternative for antibiotics | In clinical trials | Active global investigation; very few approved in veterinary use. |
Suggested starting protocol
Starting points only — clinical judgment required. Dosing unlocks for verified veterinary accounts.
No species-specific starting protocol published. Contact clinical support.
Monitoring, contraindications & do-not-use-if
Candidate-specific; investigational.
The evidence
- Peptides for Veterinary Applications — PeptideJournalPeptideJournal
- Antimicrobial Therapy in Veterinary Medicine — WileyWiley